Bayer Launches New Healthy-Aging Ecosystem for Consumers

BayerCombining a scientifically formulated dietary supplement, a leading-edge wellness companion app, and a saliva-based a biological age test by Chronomics, Bayer is taking a big step in the emerging healthy-aging space by offering consumers new tools to help them support their healthy-aging journey with its new Age Factor™ ecosystem.

The ecosystem approach is designed to go "beyond the pill" by addressing key consumer needs at multiple steps in their health journey from awareness, education, and engagement to assessment and action. Powered by digital tools, the goal is to help consumers make smarter, more informed decisions about their own health.

"Precision health is making self-care even more consumer-centric," said Julio Triana, president of the Consumer Health division of Bayer. "Our aging journeys are unique to us all and new digital tools are enabling offerings to be more tailor made. With this multi-facedted approach, we are educating and enabling consumers to to make informed decisions about their self-care in new and exciting ways."

One A Day® Age Factor™ Cell Defense

As people age, their cells naturally become less effective at managing everyday stressors. Cellular or biological age - how a person's cells are aging - may not always match one’s chronological age. Research suggests that genetics contributes only about 20% to the cellular aging process, with lifestyle (diet, exercise, stress) playing a large role. One A Day® Age Factor™ Cell Defense has key ingredients to help support consumers' cellular health and resilience as part of their healthy aging journey.

"The healthy aging space can be a confusing one for consumers with countless products making big promises," said Abbie Lennox, Head of Regulatory, Medical, Safety, Quality and Compliance for Consumer Health at Bayer. "That's why we took a science-led approach that focuses on the holistic factors that impact cellular age by equipping consumers with a product containing a key ingredient that helps defend against oxidative stress along with personalized recommendations and insights to best chart their own course."

Designed to provide holistic support along their healthy aging journey, the Age Factor™ ecosystem includes a dietary supplement, a wellness companion app, and a Chronomics biological age test to measure and track personal progress over time.

  • The Age Factor™ wellness companion app provides valuable insights and lifestyle recommendations based on a person’s current habits while tracking progress over time.
  • The Chronomics biological age test is a simple and convenient way to measure biological age through a non-invasive saliva test. Once sent to the lab, the sample will be analyzed and results received within weeks.

Benefit claims for Age Factor Cell Defense supplement have not been evaluated by the U.S. Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Precision Health

Technology advancements have enabled a wave of new digital products such as diagnostics, apps, and therapeutics to help consumers better manage their health. An analysis conducted for Bayer found over 80 percent of consumers globally already demand greater healthcare personalization and precision consumer health products will make up 10-20 percent of the total consumer health market in 2030 worth an estimated value of $20-40 billion.

Last year Bayer launched a new business unit focused on developing new precision consumer health products.

About Bayer

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission, "Health for all, Hunger for none," the company's products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2023, the Group employed around 100,000 people and had sales of 47.6 billion euros. R&D expenses before special items amounted to 5.8 billion euros.

Most Popular Now

500 Patient Images per Second Shared thr…

The image exchange portal, widely known in the NHS as the IEP, is now being used to share as many as 500 images each second - including x-rays, CT, MRI...

Jane Stephenson Joins SPARK TSL as Chief…

Jane Stephenson has joined SPARK TSL as chief executive as the company looks to establish the benefits of SPARK Fusion with trusts looking for deployable solutions to improve productivity. Stephenson joins...

Is Your Marketing Effective for an NHS C…

How can you make sure you get the right message across to an NHS chief information officer, or chief nursing information officer? Replay this webinar with Professor Natasha Phillips, former...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

Telehealth Significantly Boosts Treatmen…

New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both telemedicine and support from peers with lived experience in drug...

AI can Predict Study Results Better than…

Large language models, a type of AI that analyses text, can predict the results of proposed neuroscience studies more accurately than human experts, finds a new study led by UCL...

Using AI to Treat Infections more Accura…

New research from the Centres for Antimicrobial Optimisation Network (CAMO-Net) at the University of Liverpool has shown that using artificial intelligence (AI) can improve how we treat urinary tract infections...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

New Guidance for Ensuring AI Safety in C…

As artificial intelligence (AI) becomes more prevalent in health care, organizations and clinicians must take steps to ensure its safe implementation and use in real-world clinical settings, according to an...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...